SCHEMBL6747144

SCHEMBL6747144

CN1CC2(C)CCCC(C)(C1)C2C=C1SCCCS1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6747801 0.70
SCHEMBL10727562 0.58
SCHEMBL24756417 0.54
SCHEMBL12743651 0.54
SCHEMBL10735274 0.54 SLC6A4 (0.47)
SCHEMBL19122081 0.54 SLC6A4 (0.47)
SCHEMBL24575158 0.54 SLC6A4 (0.47)
SCHEMBL7141827 0.53 TSHR (0.40)
SCHEMBL14826670 0.52 SMN1; SMN2 (0.52)
SCHEMBL9944702 0.51

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040092737-A1 Benzopiperidine derivatives EISAI CO., LTD. 2004-05-13 US disclosed
US-6518423-B1 These compounds are useful as drugs efficacious in the prevention and treatment of these various inflammatory diseases and immunologic diseases, such as rheumatoid arthritis, atopic dermatitis, psoriasis, asthma, and EISAI CO., LTD. (JP) 2003-02-11 US disclosed
EP-0934941-A1 BENZOPIPERIDINE DERIVATIVES Eisai Co., Ltd. (JP) 1999-08-11 EP disclosed